Annual report pursuant to Section 13 and 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v2.4.1.9
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2014
Accounting Policies [Abstract]  
Schedule of Franchisor Disclosure [Table Text Block]
   
Year Ended
 December 31,
 
   
2014
   
2013
 
 Clinics open at beginning of period
    175       82  
 Clinics opened during the period
    73       93  
 Clinics closed during the period
    (2 )     -  
 Clinics in operation at the end of the period
    246       175  
                 
 Clinics sold but not yet operational
    268       223  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Year Ended
December 31,
 
   
2014
   
2013
 
             
Net income (loss)
  $ (3,031,220 )   $ 155,635  
                 
Weighted average common shares outstanding - basic
    5,451,851       5,313,665  
Effect of dilutive securities:
               
Stock options
    -       21,732  
Shares issuable on conversion of preferred stock
    -       1,335,000  
Weighted average common shares outstanding - diluted
    5,451,851       6,670,397  
                 
Basic earnings per share
  $ (0.56 )   $ 0.03  
Diluted earnings per share
  $ (0.56 )   $ 0.02  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   
Year Ended
December 31,
 
   
2014
   
2013
 
Unvested restricted stock
    590,873       -  
Stock options
    312,995       -  
Warrants
    90,000       -